Literature DB >> 3555586

Captopril + hydrochlorothiazide 24 h ambulatory monitoring effects.

R G Asmar, B M Pannier, C J Hugue, S Laurent, A Safavian, M E Safar.   

Abstract

The purpose of this study was to evaluate over a 24 h period the antihypertensive effect of captopril 50 mg + hydrochlorothiazide (HCTZ) 25 mg once a day in mild to moderate hypertension. Ambulatory recordings over 24 h of the blood pressure using the Spacelabs system were performed, at the end of a 15-day placebo period and after giving captopril + HCTZ for 45 days. Captopril + HCTZ significantly decreased (P less than 0.001) systolic and diastolic blood pressures for both the diurnal period (8 h to 22 h) and the nocturnal period (22 h to 8 h). No change in heart rate was observed. For further analysis, the mean hour values of blood pressure and heart rate were calculated. A constant decrease of the systolic and diastolic blood pressure throughout the 24 h was obtained after captopril + HCTZ without any change in heart rate and in nyctohemeral variations. The study provided evidence that, in patients with mild to moderate essential hypertension, captopril + HCTZ once a day decreased systolic and diastolic blood pressure all day long without any change in the heart rate and the blood pressure nyctohemeral cycle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3555586      PMCID: PMC1386049          DOI: 10.1111/j.1365-2125.1987.tb03125.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.

Authors:  M H Weinberger
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  Long-term experience with captopril in severe hypertension.

Authors:  J Havelka; H J Boerlin; A Studer; P Greminger; W Tenschert; T Luescher; W Siegenthaler; W Vetter; P Walger; H Vetter
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Effects of captopril, hydrochlorothiazide, and their combination on timed urinary excretions of water and solutes.

Authors:  W P Leary; A J Reyes; K V van der Byl; T N Acosta-Barrios
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

4.  Efficacy of low-dose captopril given twice daily to patients with essential hypertension uncontrolled by a beta blocker plus thiazide diuretic.

Authors:  G Muiesan; C Alicandri; E Agabiti-Rosei; R Fariello; E Montini; M L Muiesan; E Boni; A Cinquegrana; A Zaninelli
Journal:  J Int Med Res       Date:  1984       Impact factor: 1.671

5.  Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.

Authors:  C Richer; B Giroux; P F Plouin; B Maarek; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

6.  Captopril in the treatment of the elderly hypertensive patient.

Authors:  A C Jenkins; J R Knill; G R Dreslinski
Journal:  Arch Intern Med       Date:  1985-11
  6 in total
  1 in total

1.  Pharmacokinetics and biological effects of captopril and hydrochlorothiazide after acute and chronic administration either alone or in combination in hypertensive patients.

Authors:  J F Giudicelli; C Richer; A Mattei
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.